Multiple myeloma (MM) is the most frequent cancer to involve the skeleton with patients
develo** osteolytic bone lesions due to hyperactivation of osteoclasts and suppression of …

Multiple myeloma (MM) is a clonal B-cell disorder characterized by the proliferation of
malignant plasma cells (PCs) in the bone marrow, the presence of monoclonal serum …

Multiple myeloma is a plasma cell malignancy that causes debilitating bone disease and
fractures, in which TGFβ plays a central role. Current treatments do not repair existing …

Panniculitis is an inflammatory process localized to subcutaneous tissue, with etiologies
including infection, malignancy, external insults, enzymatic destructive processes, and …

Painful skeletal osteolytic metastases, impending pathological fractures, and nondisplaced
fractures present as a devastating clinical problem in advanced stage cancer patients. Open …

Simple Summary Multiple myeloma is a plasma cell cancer with bone destruction and is still
considered an incurable disease despite advancements in its treatment. Over 90% of …

Simple Summary While MRI is primarily used for vitality analysis in multiple myeloma, the
detection of osteolytic manifestations in the mineralized bone is performed on CT scans. For …

Multiple myeloma (MM) patients frequently present with extensive osteolytic bone lesions.
However, the impact of myeloma treatment on focal lytic lesion remineralization has not …

Background: Detection of lytic bone lesions is crucial in the workup for multiple myeloma
(MM) and very often dictates the decision to start treatment. Modern imaging techniques …

Multiple myeloma (MM) is an incurable plasma cell malignancy that evolves from a
premalignant condition termed monoclonal gammopathy of undetermined significance …